Hongyun Biology Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $14.6M

  • Investors
  • 9

Hongyun Biology General Information

Description

Developer of new drugs based on structural pharmacology. The company focuses on unmet medical needs comes from the bedside, such as cancer drug resistance and untreatable diseases, enabling patients to attain innovative therapeutics.

Contact Information

Website
redcloudbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 307-311, Building 9, No. 699-8, Xuanwu Avenue
  • Xuanwu District
  • Nanjing, Jiangsu
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Room 307-311, Building 9, No. 699-8, Xuanwu Avenue
  • Xuanwu District
  • Nanjing, Jiangsu
  • China

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hongyun Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B1) 15-May-2023 $14.6M Completed Clinical Trials - General
3. Early Stage VC (Series B) 17-Jun-2021 Completed Clinical Trials - General
2. Early Stage VC (Series A) 28-Feb-2020 Completed Clinical Trials - General
1. Seed Round 01-Jun-2018 Completed Startup
To view Hongyun Biology’s complete valuation and funding history, request access »

Hongyun Biology Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alpha Asset Management China Asset Manager Minority
Fan Zhuo Capital Corporate Venture Capital Minority
Huayin Financial Investment Asset Manager Minority
Lotus Lake Ventures Venture Capital Minority
Co-Win Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Hongyun Biology FAQs

  • When was Hongyun Biology founded?

    Hongyun Biology was founded in 2018.

  • Where is Hongyun Biology headquartered?

    Hongyun Biology is headquartered in Nanjing, China.

  • What industry is Hongyun Biology in?

    Hongyun Biology’s primary industry is Drug Discovery.

  • Is Hongyun Biology a private or public company?

    Hongyun Biology is a Private company.

  • What is Hongyun Biology’s current revenue?

    The current revenue for Hongyun Biology is .

  • How much funding has Hongyun Biology raised over time?

    Hongyun Biology has raised $30.2M.

  • Who are Hongyun Biology’s investors?

    Alpha Asset Management China, Fan Zhuo Capital, Huayin Financial Investment, Lotus Lake Ventures, and Co-Win Ventures are 5 of 9 investors who have invested in Hongyun Biology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »